Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 404 of 6351
-
New drug hope for kids with MS: ublituximab trial launches
Disease control Recruiting nowThe primary purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of ublituximab in participants ages 10 to less than (\<)18 years and body weight greater than or equal to (≥)25 kilograms (kg) to less than or equal to (≤)40 kg with RMS (Part A) …
Phase 2/3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Nasal spray could reverse sudden blindness in groundbreaking trial
Disease control Recruiting nowThis is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with vehicle control in adult participants with NAION. Approximately 272 participants who meet all eligibility criteria will b…
Phase 3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Engineered immune cells aim to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis study is a single-arm, intervention, dose-escalation clinical trial to evaluate the safety of allogeneic CD19/BCMA-targeted CAR-γδT cell in the treatment of relapsed/refractory autoimmune diseases
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a cheap breast cancer drug fix hormone recovery in prostate cancer patients?
Disease control Not yet recruitingAndrogen deprivation therapy (ADT) is a cornerstone therapy in the treatment of curable prostate cancer (PCa). However, ADT often leads to a protracted testosterone recovery period in most men or absence of complete recovery in 10-25% of cases. The hypogonadal state has significa…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New immunotherapy combo aims to improve lung cancer outcomes
Disease control Not yet recruitingThis randomized phase II exploratory clinical study aims to evaluate the efficacy and safety of SHR-1701 in patients with unresectable stage III non-small cell lung cancer (NSCLC). A total of 84 eligible patients will be randomized 1:1 into an induction immunotherapy group or a c…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis is a phase II trial in patients with locally advanced or metastatic non-small cell lung cancer harboring HER2 gene abnormalities (amplification or overexpression)with a performance status of 0 to1 who are planned to receive first-line treatment or who have falied the first-l…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for high altitude emergencies: study tests Life-Saving treatments
Disease control Not yet recruitingThis study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy …
Sponsor: Tibet Autonomous Region People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo aims to tame transplant complication
Disease control Not yet recruitingChronic graft-versus-host disease (cGvHD) is a serious condition that can happen after a stem cell or bone marrow transplant. The donor's immune cells attack the patient's body, causing inflammation, pain, and damage to organs like the skin, liver, or lungs. For patients with mod…
Phase 2 • Sponsor: Dennis Kim • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo aims to tackle deadly pancreatic cancer
Disease control Not yet recruitingThe purpose of this study is to find the highest dose of a drug, samuraciclib, that can be given with standard of care chemotherapy (gemcitabine and nab-paclitaxel) without causing very severe side effects. This is done by starting at a dose lower than the one that is used when s…
Phase 1/2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New vaccine aims to stop deadly diarrhea in kids
Vaccine Not yet recruitingThe goal of this phase 1/2a, randomized, observer-blind, age-descending, dose-finding trial is to evaluate the safety and immunogenicity of a quadrivalent synthetic oligosaccharide-based Shigella vaccine (adjuvanted IP-QSV) in adults, children, and infants in Mali. This first-in-…
Phase 1/2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 14:02 UTC
-
Could a Light-Activated cream replace surgery for cervical precancer?
Disease control Not yet recruitingHigh-grade squamous intraepithelial lesions (HSIL), encompassing cervical intraepithelial neoplasia grade 2 (CIN2) with p16 positivity and grade 3 (CIN3), are precancerous conditions that require effective intervention. This Phase II study aims to comprehensively evaluate the eff…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could less radiation be enough for some lymphoma patients?
Disease control Recruiting nowThis study is designed to evaluate the efficacy and safety of reduced-intensity radiotherapy for stage I/II low-risk nasal-type NK/T-cell lymphoma that has achieved complete remission after chemotherapy.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could two old drugs beat one for migraine prevention?
Disease control Not yet recruitingMigraine is a common and disabling neurological condition that affects quality of life, work productivity, and daily functioning. In Bangladesh, migraine is a major health problem, yet access to effective and affordable preventive treatments remains limited. Preventive (prophylac…
Phase 4 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Diabetes drug may ease dangerous fluid retention in liver disease
Disease control Recruiting nowThis study aims to evaluate beneficial effects of using dapagliflozin in cirrhotic chronic liver disease patients. We hypnotized that the use of dapagliflozin will be associated with fewer need for large volume paracentesis hence better control of ascites, fewer need for ICU admi…
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI could outshine standard tumor measurements to predict survival
Knowledge-focused Not yet recruitingPurpose: This study is developing and validating an artificial intelligence (AI)-driven system to evaluate tumor response using changes in total tumor volume. The goal is to determine whether this AI-based approach can better predict patient survival compared with the current sta…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Could a diabetes drug boost pregnancy success in women with PCOS?
Disease control Not yet recruitingThe goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle …
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can tiny bubbles make heart scans crystal clear?
Diagnosis Not yet recruitingThis is a phase III, prospective, multicenter, open-label, crossover study of the safety and efficacy of NH002-enhanced echocardiography in adult subjects with suboptimal images on non-contrast 2D transthoracic echocardiography with harmonic imaging within 30 days ahead of NH002 …
Phase 3 • Sponsor: Trust Bio-sonics, Inc. • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
Can a needle at the wrist calm Chemotherapy's queasiness?
Symptom relief By invitation onlyThis study is testing whether acupuncture at a point on the wrist called "Neiguan" can help reduce nausea and vomiting in patients undergoing stem cell transplantation. Participants will receive either real acupuncture or standard care. We hope to find a safe way to improve comfo…
Sponsor: Xiao Wang • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a single dose of ayahuasca quiet seizures that Aren't epileptic?
Disease control Recruiting nowOpen label intervention with a single dose of ayahuasca in patients with psychogenic non-epileptic seizures (PNES)
Phase 1/2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a breath of oxygen during dialysis ease a hidden heart risk?
Disease control CancelledThe purpose of this study is to assess the feasibility of supplemental oxygen delivery during hemodialysis in people with pulmonary hypertension and intradialytic hypoxemia.
Phase 1/2 • Sponsor: Duke University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC